Ursodeoxycholic acid and COVID-19 outcomes: a cohort study and data synthesis of state-of-art evidence

{ 'indexed': {'date-parts': [[2024, 7, 9]], 'date-time': '2024-07-09T00:24:43Z', 'timestamp': 1720484683068}, 'reference-count': 43, 'publisher': 'Informa UK Limited', 'funder': [ { 'DOI': '10.13039/501100004608', 'name': 'Natural Science Foundation of Jiangsu Province', 'doi-asserted-by': 'publisher'}, { 'DOI': '10.13039/501100010035', 'name': 'Outstanding Youth Foundation of Jiangsu Province', 'doi-asserted-by': 'publisher', 'award': ['BK20200005']}], 'content-domain': {'domain': ['www.tandfonline.com'], 'crossmark-restriction': True}, 'DOI': '10.1080/14787210.2024.2376153', 'type': 'journal-article', 'created': {'date-parts': [[2024, 7, 8]], 'date-time': '2024-07-08T11:53:11Z', 'timestamp': 1720439591000}, 'update-policy': 'http://dx.doi.org/10.1080/tandf_crossmark_01', 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'Ursodeoxycholic acid and COVID-19 outcomes: a cohort study and data synthesis of state-of-art ' 'evidence', 'prefix': '10.1080', 'author': [ { 'given': 'Yang', 'family': 'Yu', 'sequence': 'first', 'affiliation': [ { 'name': 'National Key Laboratory for Novel Software Technology, Nanjing ' 'University, China'}, {'name': 'Polixir.ai'}]}, { 'given': 'Guo-Fu', 'family': 'Li', 'sequence': 'additional', 'affiliation': [ { 'name': 'School of Basic Medicine and Clinical Pharmacy, China ' 'Pharmaceutical University, China'}]}, { 'given': 'Jian', 'family': 'Li', 'sequence': 'additional', 'affiliation': [{'name': 'Hospital of Nanjing University, Nanjing University, China'}]}, { 'given': 'Lu-Yao', 'family': 'Han', 'sequence': 'additional', 'affiliation': [ { 'name': 'School of Basic Medicine and Clinical Pharmacy, China ' 'Pharmaceutical University, China'}]}, { 'given': 'Zhi-Long', 'family': 'Zhang', 'sequence': 'additional', 'affiliation': [ { 'name': 'National Key Laboratory for Novel Software Technology, Nanjing ' 'University, China'}, {'name': 'Polixir.ai'}]}, { 'given': 'Tian-Shuo', 'family': 'Liu', 'sequence': 'additional', 'affiliation': [ { 'name': 'National Key Laboratory for Novel Software Technology, Nanjing ' 'University, China'}, {'name': 'Polixir.ai'}]}, { 'given': 'Shu-Xin', 'family': 'Jiao', 'sequence': 'additional', 'affiliation': [ { 'name': 'School of Basic Medicine and Clinical Pharmacy, China ' 'Pharmaceutical University, China'}]}, { 'given': 'Yu-Wei', 'family': 'Qiao', 'sequence': 'additional', 'affiliation': [ { 'name': 'School of Basic Medicine and Clinical Pharmacy, China ' 'Pharmaceutical University, China'}]}, { 'given': 'Na', 'family': 'Zhang', 'sequence': 'additional', 'affiliation': [ { 'name': 'School of Basic Medicine and Clinical Pharmacy, China ' 'Pharmaceutical University, China'}]}, { 'given': 'De-Chuan', 'family': 'Zhan', 'sequence': 'additional', 'affiliation': [ { 'name': 'National Key Laboratory for Novel Software Technology, Nanjing ' 'University, China'}]}, { 'given': 'Shao-Qiu', 'family': 'Tang', 'sequence': 'additional', 'affiliation': [{'name': 'Hospital of Nanjing University, Nanjing University, China'}]}, { 'given': 'Guo', 'family': 'Yu', 'sequence': 'additional', 'affiliation': [ { 'name': 'School of Basic Medicine and Clinical Pharmacy, China ' 'Pharmaceutical University, China'}]}], 'member': '301', 'published-online': {'date-parts': [[2024, 7, 8]]}, 'reference': [ { 'issue': '6', 'key': 'e_1_3_8_2_1', 'doi-asserted-by': 'crossref', 'first-page': '866', 'DOI': '10.1002/lt.25935', 'article-title': 'Ursodeoxycholic Acid Decreases Incidence of Primary Biliary Cholangitis ' 'and Biliary Complications After Liver Transplantation: A Meta-Analysis', 'volume': '27', 'author': 'Pedersen MR', 'year': '2021', 'unstructured': 'Pedersen MR, Greenan G, Arora S, et al. Ursodeoxycholic Acid Decreases ' 'Incidence of Primary Biliary Cholangitis and Biliary Complications After ' 'Liver Transplantation: A Meta-Analysis. Liver transplantation. 2021 ' 'Jun;27(6):866–875.', 'journal-title': 'Liver transplantation'}, {'key': 'e_1_3_8_3_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.jhep.2015.07.038'}, { 'issue': '7950', 'key': 'e_1_3_8_4_1', 'doi-asserted-by': 'crossref', 'DOI': '10.1038/s41586-022-05594-0', 'article-title': 'FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2', 'volume': '615', 'author': 'Brevini T', 'unstructured': 'Brevini T, Maes M, Webb GJ, et al. FXR inhibition may protect from ' 'SARS-CoV-2 infection by reducing ACE2. Nature. 2023 Mar ' '2;615(7950):134±.', 'journal-title': 'Nature'}, {'key': 'e_1_3_8_5_1', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/v15081738'}, { 'key': 'e_1_3_8_7_1', 'article-title': 'Effect of Ursodeoxycholic Acid on Preventing SARS-CoV-2 Infection in ' 'Patients With Liver Transplantation: a multicenter retrospective cohort ' 'study', 'author': 'Hu L', 'year': '2023', 'unstructured': 'Hu L, Zhang H, Huang C, et al. Effect of Ursodeoxycholic Acid on ' 'Preventing SARS-CoV-2 Infection in Patients With Liver Transplantation: ' 'a multicenter retrospective cohort study. QJM-INT J MED. 2023 ' '2023-Nov-09.', 'journal-title': 'QJM-INT J MED'}, {'key': 'e_1_3_8_8_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1111/joim.13630'}, {'key': 'e_1_3_8_9_1', 'doi-asserted-by': 'publisher', 'DOI': '10.3389/fcimb.2023.1178590'}, { 'key': 'e_1_3_8_10_1', 'article-title': 'Ursodeoxycholic acid does not affect the clinical outcome of SARS-CoV-2 ' 'infection: A retrospective study of propensity score-matched cohorts', 'author': 'Marrone G', 'year': '2023', 'unstructured': 'Marrone G, Covino M, Merra G, et al. Ursodeoxycholic acid does not ' 'affect the clinical outcome of SARS-CoV-2 infection: A retrospective ' 'study of propensity score-matched cohorts. Liver Int. 2023.', 'journal-title': 'Liver Int'}, { 'issue': '4', 'key': 'e_1_3_8_11_1', 'first-page': '289', 'article-title': 'Clinical efficacy of ursodeoxycholic acid in the treatment of COVID-19', 'volume': '16', 'author': 'Tianjiao T', 'year': '2023', 'unstructured': 'Tianjiao T, Huatao L, Bibo M, et al. Clinical efficacy of ' 'ursodeoxycholic acid in the treatment of COVID-19. Chin J Clin Infect ' 'Dis. 2023;16(4):289–292 and 298.', 'journal-title': 'Chin J Clin Infect Dis'}, {'key': 'e_1_3_8_12_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1186/s12879-021-06670-y'}, { 'issue': '15', 'key': 'e_1_3_8_13_1', 'doi-asserted-by': 'crossref', 'first-page': '2862', 'DOI': '10.1200/JCO.23.00057', 'article-title': 'Validity of Meta-Analytical Estimates and Hazard Ratios Quantifying ' 'Survival Benefit of Immunochemotherapy in Low PD-L1-Expressing ' 'Esophageal Squamous Cell Carcinoma', 'volume': '41', 'author': 'Yu G', 'year': '2023', 'unstructured': 'Yu G, Zhang N, Guan AJ, et al. Validity of Meta-Analytical Estimates and ' 'Hazard Ratios Quantifying Survival Benefit of Immunochemotherapy in Low ' 'PD-L1-Expressing Esophageal Squamous Cell Carcinoma. Journal of clinical ' 'oncology : official journal of the American Society of Clinical ' 'Oncology. 2023 May 20;41(15):2862–2864.', 'journal-title': 'Journal of clinical oncology : official journal of the American Society ' 'of Clinical Oncology'}, { 'key': 'e_1_3_8_14_1', 'unstructured': 'Wells GA Shea B O’Connell D et al. The Newcastle-Ottawa Scale (NOS) for ' 'assessing the quality of nonrandomised studies in meta-analyses. 2000.'}, { 'key': 'e_1_3_8_15_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1097/EDE.0000000000000733'}, {'key': 'e_1_3_8_16_1', 'doi-asserted-by': 'publisher', 'DOI': '10.7326/M16-2607'}, {'key': 'e_1_3_8_17_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1177/0962280216669183'}, {'key': 'e_1_3_8_18_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1136/gutjnl-2020-323366'}, {'key': 'e_1_3_8_19_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.mce.2022.111618'}, {'key': 'e_1_3_8_20_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/ncomms10713'}, {'key': 'e_1_3_8_21_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1007/s00216-018-1183-7'}, {'key': 'e_1_3_8_22_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1001/archderm.143.6.757'}, { 'key': 'e_1_3_8_23_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.jchromb.2005.08.016'}, {'key': 'e_1_3_8_24_1', 'doi-asserted-by': 'publisher', 'DOI': '10.14814/phy2.15368'}, {'key': 'e_1_3_8_25_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.jhep.2012.02.014'}, {'key': 'e_1_3_8_26_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/nrgastro.2015.12'}, { 'key': 'e_1_3_8_27_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1371/journal.pone.0234765'}, { 'key': 'e_1_3_8_28_1', 'unstructured': 'China updates COVID-19 diagnosis treatment protocol [Internet]. 2023 ' '[cited 2023]. Available from: ' 'http://english.nmpa.gov.cn/2023-01/10/c_861471.htm'}, { 'key': 'e_1_3_8_29_1', 'article-title': 'FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2', 'author': 'Brevini T', 'year': '2022', 'unstructured': 'Brevini T, Maes M, Webb GJ, et al. FXR inhibition may protect from ' 'SARS-CoV-2 infection by reducing ACE2. Nature. 2022 Dec 5.', 'journal-title': 'Nature'}, {'key': 'e_1_3_8_30_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/s41591-021-01310-z'}, {'key': 'e_1_3_8_31_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.cell.2020.04.004'}, { 'issue': '1', 'key': 'e_1_3_8_32_1', 'doi-asserted-by': 'crossref', 'first-page': '43', 'DOI': '10.1007/s40265-021-01639-2', 'article-title': 'Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor ' 'Blocker Use Associated with Reduced Mortality and Other Disease ' 'Outcomes in US Veterans with COVID-19', 'volume': '82', 'author': 'Rizk JG', 'year': '2022', 'unstructured': 'Rizk JG, Wenziger C, Tran D, et al. Angiotensin-Converting Enzyme ' 'Inhibitor and Angiotensin Receptor Blocker Use Associated with Reduced ' 'Mortality and Other Disease Outcomes in US Veterans with COVID-19. ' 'Drugs. 2022 01 01;82(1):43–54.', 'journal-title': 'Drugs'}, { 'key': 'e_1_3_8_33_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/S2665-9913(21)00144-2'}, { 'key': 'e_1_3_8_34_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1053/j.gastro.2024.03.010'}, { 'key': 'e_1_3_8_35_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1001/jamaoncol.2023.3384'}, { 'issue': '9', 'key': 'e_1_3_8_36_1', 'doi-asserted-by': 'crossref', 'first-page': '983', 'DOI': '10.1001/jamapediatrics.2023.2465', 'article-title': 'Data Extraction and Handling Issues on Evidence Synthesis of Risk of ' 'Immunoglobulin E-Mediated Food Allergy', 'volume': '177', 'author': 'Xiao YT', 'year': '2023', 'unstructured': 'Xiao YT, Cai J, Li GF. Data Extraction and Handling Issues on Evidence ' 'Synthesis of Risk of Immunoglobulin E-Mediated Food Allergy. JAMA ' 'pediatrics. 2023 Sep 1;177(9):983.', 'journal-title': 'JAMA pediatrics'}, { 'key': 'e_1_3_8_37_1', 'doi-asserted-by': 'crossref', 'first-page': '101904', 'DOI': '10.1016/j.eclinm.2023.101904', 'article-title': 'Data reproducibility issues on evidence synthesis of adverse events ' 'associated with HER2-targeted antibody-drug conjugates', 'volume': '58', 'author': 'Wu DN', 'year': '2023', 'unstructured': 'Wu DN, Guan AJ, Li GF. Data reproducibility issues on evidence synthesis ' 'of adverse events associated with HER2-targeted antibody-drug ' 'conjugates. EClinicalMedicine. 2023 Apr;58:101904.', 'journal-title': 'EClinicalMedicine'}, {'key': 'e_1_3_8_38_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.ejim.2020.04.037'}, { 'issue': '4', 'key': 'e_1_3_8_39_1', 'article-title': 'Liver Damage and Impaired Coagulation in COVID-19 Patients: A Case ' 'Series', 'volume': '11', 'author': 'Abenavoli L', 'year': '2023', 'unstructured': 'Abenavoli L, Aquila I, Sacco MA, et al. Liver Damage and Impaired ' 'Coagulation in COVID-19 Patients: A Case Series. Diseases (Basel, ' 'Switzerland). 2023 Oct 13;11(4).', 'journal-title': 'Diseases (Basel, Switzerland)'}, { 'key': 'e_1_3_8_40_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.ajpath.2021.04.010'}, { 'issue': '3', 'key': 'e_1_3_8_41_1', 'first-page': '114', 'article-title': 'Can Ursodeoxycholic Acid Prevent SARS-CoV-2 Infection or Reduce the ' 'COVID-19 Severity? Current Knowledge and Unresolved Issues', 'volume': '3', 'author': 'Pan S', 'year': '2023', 'unstructured': 'Pan S, Zhang Y, Meng F, et al. Can Ursodeoxycholic Acid Prevent ' 'SARS-CoV-2 Infection or Reduce the COVID-19 Severity? Current Knowledge ' 'and Unresolved Issues. Infect Immun. 2023;3(3):114–119.', 'journal-title': 'Infect Immun'}, { 'key': 'e_1_3_8_42_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1053/j.gastro.2023.02.008'}, { 'key': 'e_1_3_8_43_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/S2352-3026(20)30251-9'}, { 'key': 'e_1_3_8_44_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1183/23120541.00365-2022'}, { 'key': 'e_1_3_8_45_1', 'unstructured': 'Clinical Spectrum of SARS-CoV-2 Infection 2022. Available from: ' 'https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/'}], 'container-title': 'Expert Review of Anti-infective Therapy', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://www.tandfonline.com/doi/pdf/10.1080/14787210.2024.2376153', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2024, 7, 8]], 'date-time': '2024-07-08T11:53:24Z', 'timestamp': 1720439604000}, 'score': 1, 'resource': {'primary': {'URL': 'https://www.tandfonline.com/doi/full/10.1080/14787210.2024.2376153'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2024, 7, 8]]}, 'references-count': 43, 'alternative-id': ['10.1080/14787210.2024.2376153'], 'URL': 'http://dx.doi.org/10.1080/14787210.2024.2376153', 'relation': {}, 'ISSN': ['1478-7210', '1744-8336'], 'subject': [], 'container-title-short': 'Expert Review of Anti-infective Therapy', 'published': {'date-parts': [[2024, 7, 8]]}, 'assertion': [ { 'value': 'The publishing and review policy for this title is described in its Aims & ' 'Scope.', 'order': 1, 'name': 'peerreview_statement', 'label': 'Peer Review Statement'}, { 'value': 'http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=ierz20', 'URL': 'http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=ierz20', 'order': 2, 'name': 'aims_and_scope_url', 'label': 'Aim & Scope'}, { 'value': '2024-03-26', 'order': 0, 'name': 'received', 'label': 'Received', 'group': {'name': 'publication_history', 'label': 'Publication History'}}, { 'value': '2024-06-10', 'order': 1, 'name': 'accepted', 'label': 'Accepted', 'group': {'name': 'publication_history', 'label': 'Publication History'}}, { 'value': '2024-07-08', 'order': 2, 'name': 'published', 'label': 'Published', 'group': {'name': 'publication_history', 'label': 'Publication History'}}]}